Page last updated: 2024-08-18

cyclohexanol and Abnormalities, Drug-Induced

cyclohexanol has been researched along with Abnormalities, Drug-Induced in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Steiner, M1
Barrera, M; Feldman, B; Koren, G; Nulman, I; Pulver, A; Rovet, J; Streiner, D1
Polen, KN; Rasmussen, SA; Reefhuis, J; Riehle-Colarusso, T1
Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Unsal, M; Yaris, E; Yaris, F1
Källén, B; Lennestål, R1
Lederer, J1
Addis, A; Brochu, J; Chambers, C; Einarson, A; Einarson, TR; Fatoye, B; Koren, G; Lavigne, SV; Mastroiacovo, P; Matsui, D; Sarkar, M; Schuler, L1

Reviews

1 review(s) available for cyclohexanol and Abnormalities, Drug-Induced

ArticleYear
[Sweetening agents: saccharin--cyclamate and its metabolites--aspartame].
    Revue medicale de la Suisse romande, 1980, Volume: 100, Issue:1

    Topics: Abnormalities, Drug-Induced; Animals; Aspartame; Chromosome Aberrations; Cricetinae; Cyclamates; Cyclohexanols; Cyclohexanones; Cyclohexylamines; Haplorhini; Mutation; Neoplasms; Rats; Saccharin; Sweetening Agents

1980

Other Studies

6 other study(ies) available for cyclohexanol and Abnormalities, Drug-Induced

ArticleYear
Prenatal exposure to antidepressants: how safe are they?
    The American journal of psychiatry, 2012, Volume: 169, Issue:11

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Child Behavior Disorders; Cyclohexanols; Depressive Disorder; Female; Humans; Intelligence; Male; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2012
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    The American journal of psychiatry, 2012, Volume: 169, Issue:11

    Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents, Second-Generation; Case-Control Studies; Child Behavior Disorders; Child, Preschool; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Infant; Infant, Newborn; Intelligence; Longitudinal Studies; Male; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Prospective Studies; Reference Values; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sex Factors; Venlafaxine Hydrochloride; Wechsler Scales

2012
Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007.
    Birth defects research. Part A, Clinical and molecular teratology, 2013, Volume: 97, Issue:1

    Topics: Abnormalities, Drug-Induced; Adult; Anencephaly; Antidepressive Agents, Second-Generation; Aortic Coarctation; Cleft Palate; Cyclohexanols; Female; Gastroschisis; Heart Septal Defects, Atrial; Humans; Maternal Exposure; Odds Ratio; Pregnancy; United States; Venlafaxine Hydrochloride

2013
Newer antidepressants in pregnancy: prospective outcome of a case series.
    Reproductive toxicology (Elmsford, N.Y.), 2004, Volume: 19, Issue:2

    Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Mianserin; Mirtazapine; Piperazines; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Teratogens; Triazoles; Turkey; Venlafaxine Hydrochloride

2004
Delivery outcome in relation to maternal use of some recently introduced antidepressants.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:6

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adrenergic Uptake Inhibitors; Antidepressive Agents; Birth Weight; Cyclohexanols; Databases, Factual; Delivery, Obstetric; Female; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Mianserin; Mirtazapine; Morpholines; Pregnancy; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Reboxetine; Registries; Selective Serotonin Reuptake Inhibitors; Smoking; Sweden; Venlafaxine Hydrochloride

2007
Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.
    The American journal of psychiatry, 2001, Volume: 158, Issue:10

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Abortion, Therapeutic; Birth Weight; Cyclohexanols; Depressive Disorder; Female; Gestational Age; Humans; Infant, Newborn; Maternal Exposure; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Smoking; Venlafaxine Hydrochloride

2001